by Ket Patel | Oct 5, 2012 | All Articles For Neurology, Headache/Migraine
Roughly 40% of the cost of 6 months of onabotulinumtoxinA for the treatment of chronic migraine is offset by resultant decreased use of emergency departments, urgent care facilities, and migraine-related hospitalizations, according to a prospective, real-world,...
by Ket Patel | Oct 4, 2012 | All Articles For Neurology, Stroke
Prof.Dr.C.Dettmers Kliniken Schmieder Konstanz, Konstanz, Germany; Faculty of Psychology, University Konstanz, Konstanz, Germany. Mental training has been widely recommended for stroke rehabilitation (Sharma, Pomeroy, & Baron, 2006). The potential value of motor...
by Ket Patel | Oct 4, 2012 | ADHD, All Articles For Psychiatry
An extended-release liquid formulation of methylphenidate, taken once a day, has been approved by the Food and Drug Administration for treating attention-deficit/hyperactivity disorder. The concentration of the oral suspension is 5 mg/mL. The recommended dose for...
by Ket Patel | Oct 2, 2012 | All Articles For Neurology, Multiple Sclerosis
Dr. Maria Pia Sormani Department of Health Sciences, University of Genova, Italy Victoria Murphy: My guest today is Dr. Maria Pia Sormani from the department of health sciences, university of Genova, Italy. Today we are here to discuss a paper you authored in The...
by Ket Patel | Oct 1, 2012 | Slider Content
Depression in patients with episodic migraine is an independent risk factor for transformation of their headache pattern into far more burdensome chronic migraine, according to data from the landmark American Migraine Prevalence and Prevention study. “The study...
